| Primary |
| Pain |
24.2% |
| Drug Use For Unknown Indication |
17.2% |
| Sedation |
7.0% |
| Depression |
5.4% |
| Product Used For Unknown Indication |
5.4% |
| Procedural Pain |
4.8% |
| Colonoscopy |
4.3% |
| Endoscopy |
4.3% |
| Nausea |
3.2% |
| Renal Colic |
3.2% |
| Sedative Therapy |
3.2% |
| Chills |
2.7% |
| Cataract Operation |
2.2% |
| Gastritis Prophylaxis |
2.2% |
| Migraine |
2.2% |
| Postoperative Analgesia |
2.2% |
| Renal Pain |
2.2% |
| Analgesia |
1.6% |
| Surgery |
1.6% |
| Abdominal Pain |
1.1% |
|
| Convulsion |
8.6% |
| Respiratory Depression |
8.6% |
| Serotonin Syndrome |
8.6% |
| Completed Suicide |
7.1% |
| Unresponsive To Stimuli |
7.1% |
| Urticaria |
7.1% |
| Respiratory Arrest |
5.7% |
| Sedation |
5.7% |
| Swelling Face |
5.7% |
| Cardio-respiratory Arrest |
4.3% |
| Hypotension |
4.3% |
| Overdose |
4.3% |
| Anaphylactic Reaction |
2.9% |
| Drug Hypersensitivity |
2.9% |
| Hypoxia |
2.9% |
| Incorrect Dose Administered |
2.9% |
| Infusion Site Erythema |
2.9% |
| Injection Site Urticaria |
2.9% |
| Loss Of Consciousness |
2.9% |
| Medication Error |
2.9% |
|
| Secondary |
| Pain |
21.3% |
| Drug Use For Unknown Indication |
18.4% |
| Product Used For Unknown Indication |
14.7% |
| General Anaesthesia |
7.8% |
| Back Pain |
4.6% |
| Anaesthesia |
4.1% |
| Depression |
3.6% |
| Sedation |
3.6% |
| Nausea |
2.8% |
| Cancer Pain |
2.6% |
| Type 2 Diabetes Mellitus |
2.4% |
| Prophylaxis |
2.0% |
| Vomiting |
1.8% |
| Drug Abuse |
1.6% |
| Hyperaesthesia |
1.6% |
| Suicide Attempt |
1.6% |
| Hepatic Pain |
1.5% |
| Maternal Exposure During Pregnancy |
1.5% |
| Analgesia |
1.3% |
| Hypertension |
1.3% |
|
| Completed Suicide |
15.8% |
| Respiratory Arrest |
12.9% |
| Serotonin Syndrome |
8.9% |
| Somnolence |
6.9% |
| Respiratory Failure |
5.9% |
| Drug Toxicity |
5.0% |
| Medication Error |
5.0% |
| Cardio-respiratory Arrest |
4.0% |
| Hypotension |
4.0% |
| Uterine Contractions During Pregnancy |
4.0% |
| Death |
3.0% |
| Liver Function Test Abnormal |
3.0% |
| Oesophageal Atresia |
3.0% |
| Pain |
3.0% |
| Pneumonia Pneumococcal |
3.0% |
| Psychotic Disorder |
3.0% |
| Vomiting |
3.0% |
| Weight Decreased |
3.0% |
| Abdominal Pain |
2.0% |
| Anaphylactic Reaction |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.5% |
| Drug Use For Unknown Indication |
29.0% |
| Pain |
7.2% |
| Hypertension |
3.0% |
| Nausea |
2.1% |
| Depression |
2.0% |
| Prophylaxis |
2.0% |
| Mantle Cell Lymphoma |
1.7% |
| Constipation |
1.7% |
| Breast Cancer |
1.5% |
| Acute Myeloid Leukaemia |
1.4% |
| Abdominal Distension |
1.3% |
| Premedication |
1.1% |
| Chronic Lymphocytic Leukaemia |
1.0% |
| Anxiety |
1.0% |
| Diarrhoea |
0.9% |
| Pyrexia |
0.9% |
| Thrombosis Prophylaxis |
0.9% |
| Abdominal Pain |
0.8% |
| Chills |
0.8% |
|
| Vomiting |
8.8% |
| Weight Decreased |
8.8% |
| Weight Increased |
8.2% |
| Thrombocytopenia |
6.6% |
| Type 2 Diabetes Mellitus |
6.6% |
| Sepsis |
6.0% |
| Unresponsive To Stimuli |
6.0% |
| Premature Baby |
5.5% |
| Renal Failure Acute |
4.9% |
| Pancreatitis |
4.4% |
| Skin Tightness |
4.4% |
| Pulmonary Congestion |
3.8% |
| Pulmonary Embolism |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Nausea |
3.3% |
| Pain |
3.3% |
| Ventricular Tachycardia |
3.3% |
| Abdominal Pain |
2.7% |
| Aggression |
2.7% |
| Hypertension |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
42.9% |
| Product Used For Unknown Indication |
23.8% |
| Lymphoma |
9.5% |
| Pain |
9.5% |
| Abdominal Pain |
4.8% |
| Back Pain |
4.8% |
| Ill-defined Disorder |
4.8% |
|
| Drug Interaction |
22.2% |
| Hallucination, Visual |
22.2% |
| Sudden Death |
22.2% |
| Toxicity To Various Agents |
22.2% |
| Respiratory Arrest |
11.1% |
|
